Evidence map›Paper›PMID 36537829›Full record

ArticleAnalytical chemistry2023

Biocompatible Monophosphonated Trityl Spin Probe, HOPE71, for In Vivo Measurement of pO

Teresa D Gluth, Martin Poncelet, Marieta Gencheva, Emily H Hoblitzell, Valery V Khramtsov, Timothy D Eubank, Benoit Driesschaert

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Teresa D GluthDepartment of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown, West Virginia26506, United States.
Martin PonceletDepartment of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown, West Virginia26506, United States.
Marieta GenchevaIn Vivo Multifunctional Magnetic Resonance Center, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, West Virginia26506, United States.
Emily H HoblitzellIn Vivo Multifunctional Magnetic Resonance Center, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, West Virginia26506, United States.
Valery V KhramtsovIn Vivo Multifunctional Magnetic Resonance Center, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, West Virginia26506, United States.ORCID 0000-0001-6187-5546
Timothy D EubankIn Vivo Multifunctional Magnetic Resonance Center, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, West Virginia26506, United States.
Benoit DriesschaertDepartment of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown, West Virginia26506, United States.ORCID 0000-0002-1402-413X
West Virginia University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
In vivo monitoring of tumor microenvironment regulation for macrophagesR01CA194013 · NCI · WEST VIRGINIA UNIVERSITY · PI Timothy D Eubank, Valery V Khramtsov · 2015 to 2026
$3.5M
Profiling chemical tumor microenvironment: Application for diagnostics & therapyR01CA192064 · NCI · WEST VIRGINIA UNIVERSITY · PI EUBANK, TIMOTHY D, KHRAMTSOV, VALERY V · 2015 to 2024
$3.4M
Biocompatible triarylmethyl radical-based dendrimers as nonmetallic contrast agents for MRIR01EB032321 · NIBIB · WEST VIRGINIA UNIVERSITY · PI DRIESSCHAERT, BENOIT · 2022 to 2025
$1.5M
Biocompatible Magnetic Resonance Probes for in vivo Concurrent Profiling R00EB023990 · NIBIB · WEST VIRGINIA UNIVERSITY · PI DRIESSCHAERT, BENOIT · 2019 to 2021
$730k
Imaging enzyme activity by Overhauser-enhanced MRIR21EB028553 · NIBIB · WEST VIRGINIA UNIVERSITY · PI DRIESSCHAERT, BENOIT · 2020 to 2022
$599k
Electron Spin Resonance Microfluidics as a new tool in chemical single cell population analysisR21GM143595 · NIGMS · WEST VIRGINIA UNIVERSITY · PI BLANK, AHARON, DRIESSCHAERT, BENOIT · 2022 to 2023
$387k
NCI NIH HHS R01 CA192064NCI NIH HHS R01 CA194013NIBIB NIH HHS R00 EB023990NIBIB NIH HHS R01 EB032321NIBIB NIH HHS R21 EB028553NIGMS NIH HHS R21 GM143595NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

Hypoxia, acidosis, and elevated inorganic phosphate concentration are characteristics of the tumor microenvironment in solid tumors. There are a number of methods for measuring each parameter individually in vivo, but the only method to date for noninvasive measurement of all three variables simultaneously in vivo is electron paramagnetic spectroscopy paired with a monophosphonated trityl radical, pTAM/HOPE. While HOPE has been successfully used for in vivo studies upon intratissue injection, it cannot be delivered intravenously due to systemic toxicity and albumin binding, which causes significant signal loss. Therefore, we present HOPE71, a monophosphonated trityl radical derived from the very biocompatible trityl probe, Ox071. Here, we describe a straightforward synthesis of HOPE71 starting with Ox071 and report its EPR sensitivities to pO

Indexed as

Electron Spin Resonance SpectroscopyNeoplasmsOxygenTriphenylmethyl CompoundsAnimalsBiosensing TechniquesHydrogen-Ion ConcentrationHypoxiaMiceTumor MicroenvironmentOxygenTriphenylmethyl Compounds

Identifiers

PMID36537829
PMCPMC9852220
OpenAlexW4312019514

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.